We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Notifications of Suspected Counterfeit Drugs Would Limit Distribution, FDA Says
Notifications of Suspected Counterfeit Drugs Would Limit Distribution, FDA Says
Drugmakers should notify the FDA and any affected trading partner within 24 hours of encountering suspected counterfeit products to prevent or limit them from entering or being distributed in the supply chain, the agency says in a notice published in Tuesday’s Federal Register.